[1]
“Effect of Hydroxymethylglutaryl-CoA Reductase Inhibitors on Low-density Lipoprotein Cholesterol, Interleukin-6, and High-Sensitivity C-Reactive Protein in End-stage Renal Disease”,
IJKD, vol. 5, no. 1, pp. 29–33, Dec. 2010, Accessed: Jul. 12, 2025. [Online]. Available:
https://ijkd.org/index.php/ijkd/article/view/209